| |
|
|
Drug name
|
Condition |
Division |
| Letairis™ (ambrisentan) |
Pulmonary Hypertension |
Accredo Therapeutics |
| Leukine® (sargramostim) |
Anemia/Neutropenia |
Accredo Nova Factor |
| Leuprolide (generic) |
Oncology |
Accredo Nova Factor |
| Lovenox® (enoxaparin sodium) |
DVT/Anticoagulation |
Accredo Nova Factor |
| Lucentis® (ranibizumab) |
AMD/Age-related Macular Degeneration |
Accredo Nova Factor |
| Lupron® (leuprolide acetate) |
Oncology |
Accredo Nova Factor |
| Lupron Depot® (leuprolide acetate) |
Oncology |
Accredo Nova Factor |
| Lupron Depot® 3-Month (leuprolide acetate) |
Oncology |
Accredo Nova Factor |
| Lupron Depot-PED® (leuprolide acetate) |
Growth Disorders |
Accredo Nova Factor |
| Luveris® (lutropin alfa) |
Infertility |
Accredo Nova Factor |